Antibasal ganglia antibodies, immunomodulation, and antibiotics in "poststreptococcal" adult neuropsychiatric disorders: not yet ready for "prime time".
Antonio L
AL
Teixeira
Leonardo F
LF
Fontenelle
Mauro V
MV
Mendlowicz
Edward C
EC
Lauterbach
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology*; D001479:Basal Ganglia / Q000276:immunology*; D002389:Catatonia / Q000188:drug therapy / Q000276:immunology*; D003937:Diagnosis, Differential; D004421:Dystonia / Q000188:drug therapy / Q000276:immunology*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008590:Meningoencephalitis / Q000188:drug therapy / Q000276:immunology*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000276:immunology*; D012307:Risk Factors; D013290:Streptococcal Infections / Q000188:drug therapy / Q000276:immunology*; D020323:Tics / Q000188:drug therapy / Q000276:immunology*
D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D007155:Immunologic Factors